NanoView Biosciences Revenue and Competitors
Estimated Revenue & Valuation
- NanoView Biosciences's estimated annual revenue is currently $1.2M per year.
- NanoView Biosciences's estimated revenue per employee is $84,000
Employee Data
- NanoView Biosciences has 14 Employees.
- NanoView Biosciences grew their employee count by -67% last year.
NanoView Biosciences's People
| Name | Title | Email/Phone |
|---|---|---|
1 | US Service Manager | Reveal Email/Phone |
NanoView Biosciences Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $3.4M | 30 | -21% | N/A | N/A |
#2 | $2.7M | 28 | N/A | N/A | N/A |
#3 | $4M | 51 | 50% | $32M | N/A |
#4 | $55.3M | 521 | 11% | $14.8M | N/A |
#5 | $1.1M | 9 | -25% | N/A | N/A |
#6 | $0.9M | 8 | -20% | N/A | N/A |
#7 | $3.7M | 33 | N/A | N/A | N/A |
#8 | $1.8M | 26 | 53% | $81.7M | N/A |
#9 | $5.2M | 47 | 0% | $1.5M | N/A |
#10 | $0.3M | 4 | N/A | N/A | N/A |
What Is NanoView Biosciences?
NanoView Biosciences, is developing proprietary products that support research, translation and delivery of precision medicine. The Company was founded on a novel technology platform that uniquely identifies and characterizes exosomes. Our high-throughput, cost-effective analysis solutions enable life science researchers to better understand the biology of cellular communication and provide improved insight for how diseases are diagnosed, treated and monitored.
keywords:N/A
N/A
Total Funding
14
Number of Employees
$1.2M
Revenue (est)
-67%
Employee Growth %
N/A
Valuation
N/A
Accelerator
NanoView Biosciences News
2022-04-20 - Global Nucleic Acid Labeling Market 2022 Data Analysis and ...
... Vector Laboratories, Promega Corporation, Agilent Technologies, Thermo Fisher Scientific, Inc, NanoView Biosciences Inc.
Other Companies in Boston
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $1.5M | 14 | -12% | N/A |
#2 | $1M | 14 | 0% | $50M |
#3 | $1.8M | 14 | N/A | N/A |
#4 | $1.7M | 14 | N/A | N/A |
#5 | $0.9M | 14 | 0% | $13.3M |